0001567619-21-001335.txt : 20210121
0001567619-21-001335.hdr.sgml : 20210121
20210121162202
ACCESSION NUMBER: 0001567619-21-001335
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210119
FILED AS OF DATE: 20210121
DATE AS OF CHANGE: 20210121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anicetti Vincent R
CENTRAL INDEX KEY: 0001733375
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36721
FILM NUMBER: 21542251
MAIL ADDRESS:
STREET 1: COHERUS BIOSCIENCES, INC.
STREET 2: 333 TWIN DOLPHIN DRIVE, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coherus BioSciences, Inc.
CENTRAL INDEX KEY: 0001512762
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273615821
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 333 TWIN DOLPHIN DR, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: (650) 649-3530
MAIL ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 333 TWIN DOLPHIN DR, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: BioGenerics, Inc.
DATE OF NAME CHANGE: 20110210
4
1
doc1.xml
FORM 4
X0306
4
2021-01-19
0
0001512762
Coherus BioSciences, Inc.
CHRS
0001733375
Anicetti Vincent R
COHERUS BIOSCIENCES, INC.
333 TWIN DOLPHIN DRIVE, SUITE 600
REDWOOD CITY
CA
94065
0
1
0
0
Chief Operating Officer
Common Stock
2021-01-19
4
M
0
2500
2.5005
A
62239
D
Common Stock
2021-01-19
4
S
0
2500
17.9408
D
59739
D
Stock Option (Right to Buy)
2.5005
2021-01-19
4
M
0
2500
0.00
D
2024-06-30
Common Stock
2500
2488
D
Includes 52,083 restricted stock units.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
The transaction was executed in multiple trades in prices ranging from $17.76 to $18.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
All of the shares underlying this option are vested and exercisable as of the date hereof.
/s/ Jean-Frederic Viret, as Attorney-in-Fact for Vincent R. Anicetti
2021-01-21